ARCHIVES

Randomized Trials Discovered Roles For Newly Approved Nexavar and Sutent.

This article is from The Cancer Letter archive.

Vol. 32 No. 07 | February 24, 2006

Download PDF Visit The Full Archive

Related Articles

NCI To Invite Unaffiliated Oncologists To Enroll Patients On Phase III Trials

May 10, 2002

Nobel In Chemistry For Work Linking Carbon Atoms

October 8, 2010

Funding Opportunities

January 17, 2003

NCI To Expand SPORE Grants Program to Increase Translational Research Funding

October 22, 1999

IL13-PE38 Looks Promising In Early Tests Against Gioma

September 27, 2002

In Brief: Responses To Control Grants Guidelines Pour Into NCI, Some From Grantsmen “Old Pros”

November 23, 1974